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Abstract
Background: Following confirmation of the effectiveness of voluntary medical male circumcision (VMMC) for HIV
prevention, the World Health Organization and the Joint United Nations Programme on HIV/AIDS issued recommendations
in 2007. Less than 5 y later, priority countries are at different stages of program scale-up. This paper analyzes the progress
towards the scale-up of VMMC programs. It analyzes the adoption of VMMC as an additional HIV prevention strategy and
explores the factors may have expedited or hindered the adoption of policies and initial program implementation in priority
countries to date.
Methods and Findings: VMMCs performed in priority countries between 2008 and 2010 were recorded and used to classify
countries into five adopter categories according to the Diffusion of Innovations framework. The main predictors of VMMC
program adoption were determined and factors influencing subsequent scale-up explored. By the end of 2010, over 550,000
VMMCs had been performed, representing approximately 3% of the target coverage level in priority countries. The ‘‘early
adopter’’ countries developed national VMMC policies and initiated VMMC program implementation soon after the release
of the WHO recommendations. However, based on modeling using the Decision Makers’ Program Planning Tool (DMPPT),
only Kenya appears to be on track towards achievement of the DMPPT-estimated 80% coverage goal by 2015, having
already achieved 61.5% of the DMPPT target. None of the other countries appear to be on track to achieve their targets.
Potential predicators of early adoption of male circumcision programs include having a VMMC focal person, establishing a
national policy, having an operational strategy, and the establishment of a pilot program.
Conclusions: Early adoption of VMMC policies did not necessarily result in rapid program scale-up. A key lesson is the
importance of not only being ready to adopt a new intervention but also ensuring that factors critical to supporting and
accelerating scale-up are incorporated into the program. The most successful program had country ownership and
sustained leadership to translate research into a national policy and program.
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In 2009, more than 25 y after HIV was first identified, 2.6
million people had become infected, and there were an estimated
33.3 million people living with HIV worldwide [1]. In the absence
of a vaccine, the next best means to combat new HIV infections is
the implementation of evidence-based prevention strategies
including male and female condoms [2], antiretroviral prophylaxis
to prevent vertical transmission from mother to child [3,4], harm
reduction for people who inject drugs [5], and, most recently,
treating HIV-infected people in serodiscordant couples with
antiretroviral drugs to reduce transmission to partners [6].
However, the scale-up of these HIV prevention programs remains
challenging despite evidence demonstrating their effectiveness.
The use of male and female condoms, despite decades of
promotion and distribution, remains suboptimal. The use of
female condoms as a prevention strategy for HIV is reportedly
lower than male condom use, including in countries in sub-
Saharan Africa, where the majority of new HIV infections are
occurring through heterosexual transmission [7] and are predom-
inantly among women.
Evidence demonstrating the effectiveness of voluntary medical
male circumcision (VMMC) in preventing HIV sexual transmis-
sion was first released in 2005 from the South Africa (Orange
Farm) randomized controlled trial (RCT) [8]. This was followed
by results in 2006 from RCTs in Uganda (Rakai District) and
Kenya (Kisumu) [9,10]. All three RCTs confirmed that male
circumcision performed by well-trained and equipped medical
providers is safe and reduces the risk of heterosexual acquisition of
HIV infection among men by as much as 60%. These RCT results
confirmed decades of evidence from observational studies
suggesting male circumcision’s strong protective effect for men
against HIV [11]. Male circumcision also has a strong protective
effect against other sexually transmitted infections in men and in
women [12–16]. Although there is no conclusive evidence that
medical male circumcision has a direct effect on women’s risk of
HIV infection [17], a systematic review, largely based on
observational studies, estimated an overall 20% lower HIV
incidence in female partners of circumcised men, compared with
partners of uncircumcised men [18].
Following the release of the results of the RCTs, in 2007 the
World Health Organization (WHO) and the Joint United Nations
Programme on HIV/AIDS (UNAIDS) convened an international
consultation of stakeholders from a range of disciplines to review
the body of evidence from the three trials and the wealth of earlier
ecological and observational studies [19]. The consultation
resulted in a firm endorsement of the evidence from the three
trials, and the formulation of eleven key conclusions and
recommendations for the implementation and scale-up of VMMC
programs in countries and settings with generalized high-
prevalence HIV epidemics and low levels of male circumcision
[19].
WHO and UNAIDS identified 13 countries in southern and
eastern African as high-priority countries for the implementation
and rapid scale-up of VMMC programs: Botswana, Kenya,
Lesotho, Malawi, Mozambique, Namibia, Rwanda, South Africa,
Swaziland, Tanzania, Uganda, Zambia, and Zimbabwe. These
countries have been working towards the implementation of
VMMC programs using operational guidance developed by
WHO and UNAIDS. The guidance emphasizes ten essential
components of program implementation: leadership and partner-
ships, situation analysis, advocacy, enabling policy and regulatory
environments, national strategy and operational plans, quality
assurance and improvement, human resource development,
commodity security, social change communication, and monitor-
ing and evaluation [20].
A consensus report of six different models showed that in
settings with high HIV prevalence and low circumcision
prevalence, one new HIV infection could be averted for every
five to 15 circumcisions performed [21]. More detailed modeling
was incorporated into the Decision Maker’s Program Planning
Tool (DMPPT), and it is estimated that scaling up circumcision
programs to reach 80% of adult uncircumcised men within 5 y in
13 priority countries would require a total of 20.3 million
circumcisions to be performed and a further 8.4 million between
2016 and 2025, averting an estimated 3.4 million new HIV
infections and 386,000 AIDS deaths through 2025 [22]. Despite
convincing results demonstrating that VMMC is an effective, cost-
saving intervention in the fight against HIV, there have been
major challenges and barriers to implementing programs in the
high priority countries.
This paper analyzes the progress towards achievement of
VMMC for HIV prevention program scale-up in 13 priority
countries. We analyze the adoption of VMMC as an additional
HIV prevention strategy. We further explore the factors that may
have expedited or hindered the adoption of VMMC policies and
strategies as well as initial program implementation in the 13
priority countries to date. We also explore the factors that may
have influenced subsequent program scale-up. Challenges en-
countered and lessons learned are highlighted for application to
countries still in the early stages of VMMC scale-up as well as to
other potential HIV prevention strategies such as topical (vaginal
and rectal microbicides) and oral pre-exposure prophylaxis.
Methods
The actual numbers of VMMCs performed in priority countries
per calendar year since 2008 were recorded and the totals used to
classify countries into five adopter categories according to the
Diffusion of Innovations (DOI) framework. Country progress
towards achievement of the goal of circumcising 80% of eligible
men was also calculated [22].
The DOI and ExpandNet frameworks were selected to analyze
the status of VMMC programming in the 13 priority countries as
they are complimentary theories that both refer to the process by
which innovations are disseminated and taken to scale. The DOI
and ExpandNet frameworks highlight the importance of the
nature of the innovation itself and the sociopolitical context or
environment in which diffusion takes place (see Figure 1). Whereas
the DOI theory addresses the diffusion of any innovation, the
WHO ExpandNet framework explicitly addresses the adoption
and scale-up of public health programs and services in the health
sector. Both frameworks stress that innovations that are Credible,
Observable, and Relevant; have Relative advantages; are Easy to
install and understand; and are Compatible and Testable
(‘‘CORRECT’’) are most likely to be successfully adopted and
scaled up [23].
The DOI theory defines diffusion as the process by which an
innovation is communicated through certain channels over time
among members of a social system [24]. The DOI theory posits
that regardless of the setting, initially there are a few individuals
who adopt innovations, known as the ‘‘innovators’’—these are
those who are willing to adopt new ideas before they are
mainstream. Following this, another small proportion, the ‘‘early
adopters,’’ of the population follow. The ‘‘early majority’’ is the
next group to adopt the innovation. By this time, more than half of
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the next group to accept new interventions; the ‘‘laggards’’ are the
last to adopt innovations, they represent those who are least likely
to accept innovation (see Figure 2). While the DOI theory refers to
the adoption pattern of individuals within a community, we
applied these concepts to analyze the adoption of VMMC policies,
strategies, and initial program implementation by countries. The
DOI framework was used to define the adoption status of each
country to comparatively assess progress towards scale-up among
the 13 priority countries.
In order to facilitate analysis using the DOI framework, six
program components based on key elements defined as essential
for the operationalization of VMMC programs described in the
WHO/UNAIDS operational guidance were used to assess overall
country progress towards VMMC program scale-up [20]. The six
elements selected were those for which progress towards scale
up over a 3-y period could be objectively quantified. A country
was assigned a score for each key element, ranging from 0
(no progress) to 3 (maximum progress). A total scale-up score, a
composite indicator of progress in program scale-up, was
calculated for each country. Additionally, further analyses were
undertaken in order to understand if there were differences in the
contributions of the six key elements to the overall DOI adoption
status, since one can argue that some elements are better
predictors of adoption and scale-up than others. To do this, the
association between the DOI classification ‘‘adopter status’’ and
the scores on the individual elements of scale-up was determined
using a crude estimation of association based on an R-squared
analysis.
The ExpandNet framework is based on the theory underpin-
ning the DOI model and supplemented with experiences apply-
ing the model in low-resource settings [25]. The ExpandNet
framework views scaling up as an open system that draws on five
interacting elements: the innovation itself, the resource team, the
scale-up strategy, the user organization, and the environment. We
used the ExpandNet framework to explore the factors that may
Figure 1. Comparison of Diffusion of Innovation and ExpandNet frameworks. A comparison of the DOI and ExpandNet frameworks is
shown. Whereas the DOI describes the process through which innovations are adopted and diffused through the population, the ExpandNet
framework specifically addresses the diffusion and scale-up of public health interventions. As highlighted in the figure, the ExpandNet framework
reflects the earlier thinking of the DOI and incorporates the elements of context as environment, communication channels as scale-up strategy, and
adoption by the population as adoption by the organization implementing the intervention.
doi:10.1371/journal.pmed.1001133.g001
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specific to VMMC.
Results
The ‘‘CORRECT’’ attributes of VMMC are highlighted in
Table 1. Male circumcision, an old procedure but an innovation
for HIV prevention, has many of the ‘‘CORRECT’’ attributes
needed to enhance scalability. VMMC is Credible, with consistent
evidence of reduced HIV rates from numerous Observational
studies and RCTs conducted by respected researchers in Africa,
where the intervention is Relevant, as it provides a new solution to
address a high-burden public health problem; VMMC has
Relative advantages, as it is a one-time intervention conferring
lifetime reduction in risk of HIV infection. Medical male
circumcision is not particularly Easy to install, as it is a surgical
intervention that requires training and expertise, with complex
social and cultural barriers that need to be overcome as programs
are scaled up. However, it is a one-time intervention, provides a
rare opportunity to reach men, and it is cost saving [22,26].
Medical male circumcision is Compatible with existing national
priorities for HIV prevention in the priority countries. In all
priority countries, VMMC services have been or are being pilot
Tested, providing critical information for moving to scale.
Table 2 shows that between 2008 and 2010, an estimated total
of 559,528 VMMCs for HIV prevention have been done in the 13
priority countries, with a large majority (417,974) done in 2010.
Kenya has carried out the largest number (232,287) of VMMCs,
followed by South Africa (145,475) and then Zambia (81,849).
Table 2 also shows the classification of countries according to DOI
adopter status. The innovator (8% of countries), Kenya, started
performing VMMCs in or before 2008 and reached more than
10,000 VMMCs in 2008. Early adopters (23% of countries), South
Africa, Zambia, and Swaziland, started in or before 2008. The
early majority (38% of countries), Botswana, Zimbabwe, Tanza-
nia, Namibia, and Mozambique started in 2009. The late majority
(15% of countries), Uganda and Rwanda, started in 2010 and did
more than 1,000 VMMCs. The laggards (15% of countries),
Malawi and Lesotho, did fewer than 1,000 VMMCs in 2010. The
distribution of the total scale-up scores reflecting adoption status
among the 13 countries in this study compares well with the
distribution proposed by the DOI theory. Also highlighted in
Table 2, only Kenya appears to be on track towards achievement
of the DMPPT-estimated 80% coverage goal by 2015, having
already achieved 61.5% of the DMPPT target. None of the other
countries—including the early adopters—appear to be on track to
achieve their targets.
Table 3 shows the scoring scheme for each of the six key
elements derived from the WHO/UNAIDS operational guidance,
reflecting also the time when the different milestones were
achieved (earlier completion resulting in higher scores). Table 4
shows the scores for each element by country and reflects the
progress in scaling up key program elements in all of the priority
countries. The total scale-up scores calculated for each of the 13
countries ranged from a low of 4 (Mozambique) to a high of 17
(Kenya) out of a maximum score of 18. To date, all countries have
conducted a situation analysis to assess the acceptability of
introducing VMMC programs with the support of a WHO toolkit
[27]. At least seven countries had conducted their situation
analyses in 2008, within a year of the release of the WHO/
UNAIDS recommendations. Beyond the conduct of the situation
analysis, progress towards the other key elements of scale-up varies
significantly among the 13 countries.
In particular, large variation is seen in the leadership scores,
with only Botswana, Kenya, Rwanda, and Swaziland having
clearly identifiable prominent national champions for VMMC.
We found that although almost all countries had a dedicated
national focal person for VMMC in place, Botswana and Kenya
had identified theirs within the first year of scale-up. Twelve out of
the 13 countries had nationally approved policies for VMMC
scale-up by the end of 2010, with Botswana and Kenya having
their policies in place within a year of the WHO/UNAIDS
recommendations. By the end of 2010, only Mozambique and
Uganda did not have nationally approved scale-up strategies.
Figure 3 summarizes the results of the R-squared analysis for
each of the six key elements of scale-up identified in this study. The
figure shows each of the 13 countries according to their DOI
classification and their scores on the individual elements of
VMMC program scale-up (Table 4), together with a crude
estimate of association (R-squared) computed by assigning a linear
score to the DOI classes. The association values can range from 0
to 1, with an R-squared value of 1 indicating perfect association.
For this analysis, the association values ranged from 0.16 to 0.57.
As the results suggest, conducting a pilot program (R-squared =
0.57) may be the most important predictor of DOI class, followed
by establishing a male circumcision focal point (R-squared =
0.27), developing a national male circumcision policy (R-squared
= 0.27), and developing a national implementation strategy
Figure 2. Diffusion of Innovation adoption status. The typical distribution of categories of adopters according to the DOI theory is shown in
this figure. The very first adopters or innovators typically represent 2.5% of the population. The next group of adopters, called early adopters,
represent about 13.5% of the population and are followed by the early majority, who represent approximately 34% of the total population. The next
34% of the population to adopt are the late majority; this group is followed by the remaining 16% of the population, who are the laggards, the last to
adopt a new innovation.
doi:10.1371/journal.pmed.1001133.g002
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Innovation Element Key Questions for Scale-Up Male Circumcision
Credible 1. Have results of pilot testing the innovation been
documented? 2. How sound is the evidence? 3. Is
further evidence/better documentation needed? 4.
Has the innovation been tested in the type of setting
where it will be scaled up?
Ecological studies show lower prevalence of HIV infection in
countries with high rates of circumcision.
Epidemiological studies show that circumcised men have a
consistently lower incidence of HIV than uncircumcised men, even
after adjusting for differences in sexual behavior.
Three independent RCTs showed that circumcision reduced the risk of
HIV infection in young men.
Research was conducted by credible researchers in directly relevant
settings in African countries.
Male circumcision is not a new procedure, but is an innovation for
HIV prevention, with potential for significant impact in countries with
generalized HIV epidemics and low prevalence of circumcision.
Observable How observable are results? Results from the epidemiological studies and RCTs are unequivocal in
demonstrating lower HIV incidence in circumcised men.
Impact of program scale-up on incidence of HIV infection will
take some time to be realized.
Impact on AIDS and AIDS-related mortality will be even more distal.
Modeling, costing, and impact studies indicate that VMMC is
cost saving and will benefit both men and women.
Relevant Does the innovation address a felt need,
persistent problem, or policy priority?
VMMC addresses the persistent problem of finding ways to
prevent HIV in generalized heterosexual epidemics.
It is directly relevant in southern and eastern African countries
that have the greatest HIV incidence and burden of infection.
Relative advantages 1. Does the innovation have relative advantage over
existing practices? 2. Is it more cost-effective than
existing practices or alternatives?
VMMC is only a one-time intervention, resulting in lifelong
lower risk of HIV infection in men.
VMMC programs are a rare opportunity to reach young men
through health services and provide good sexual and reproductive health
and HIV risk reduction counseling.
VMMC has been demonstrated to be highly cost-effective and
cost saving for all priority countries. The potential impact is substantially
greater than other HIV prevention interventions.
Ease to install 1. What degree of change from current norms, practices,
and levels of resources is implied in the innovation? 2.
What is the level of technical sophistication needed to
introduce the innovation? 3. Are major additional
human or financial resources and commodities needed
to introduce the innovation?
VMMC is a challenging intervention to implement since it
requires surgical skills that are in short supply in the Africa region.
The number of circumcisions necessary to achieve rapid
impact on the HIV epidemic is large, with consequently potentially
large implications for human resources, facilities, and supplies.
VMMC is a straightforward minor outpatient surgical procedure,
but must be performed by adequately trained and equipped teams.
Compatible 1. Is the innovation compatible with current values or
services of the user organization? 2. Will it be
difficult to maintain the basic values of the
innovation as expansion proceeds? 3. Will changes in
logistics need to be made to accommodate the
innovation? 4. Which components will need local
adaptation to be relevant for changes in local context?
VMMC is consistent with already existing national priorities
for comprehensive HIV prevention.
There are a wide range of sociocultural factors that need
to be considered when scaling up VMMC programs.
Countries need to ensure that VMMC is promoted in a culturally sensitive
way and does not introduce stigma associated with circumcision status.
The implications of VMMC for women also need to be taken into
account when scaling up programs.
Testable Can the user organization test the innovation
in stages without fully adopting it?
Pilot projects have been set up in all 13 priority countries and tailored
to local contexts. The pilots have provided information for subsequent
program scale-up.
Lessons from Male Circumcision Program Scale-Up
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squared = 0.17) and conducting a situation analysis (R-squared
= 0.16) was shown to have a weaker predictive value on the
likelihood of VMMC adoption and program scale-up.
Specific examples of how the ‘‘user organization,’’ ‘‘resource
team,’’ scaling-up strategy, and environment influenced scale-up
are highlighted in Box 1. The type of policy document developed
varies by country: some countries have stand-alone policy
documents, while others have VMMC incorporated into other
HIV prevention policies. Governments have been engaged in the
setting up of pilot sites to test the feasibility of scale-up in all
countries.
Discussion
We found that the DOI theory was most useful in analyzing the
adoption and initial implementation of VMMC programs, while
the ExpandNet theory helped to explore the factors that have
facilitated or hindered scale-up. The analysis shows that although
progress in VMMC program implementation has been made in all
13 countries within the first 3 y of the release of the WHO/
UNAIDS recommendations, much more needs to be done if
countries are to take programs to scale and achieve their targets of
circumcising 80% of eligible men by 2015. The innovator country,
Kenya, and the early adopters (South Africa, Zambia, and
Swaziland) initiated VMMC program implementation soon after
the release of the recommendations by adopting national policies
and strategies and starting to perform VMMCs as part of pilot
programs in 2008. However, only Kenya appears to be on track to
achieving 80% coverage by 2015. To date, VMMC programs in
priority countries have reached only approximately 3% of the
target coverage level of 80% of eligible African men proposed by
Njeuhmeli et al. [22]. Clearly an accelerated pace of VMMC
service delivery is needed to take programs to scale and to
maximize the impact of the programs.
Although the rate of adoption of VMMC programs varies
among the 13 priority countries, the initiation of program
adoption and initial implementation as a whole have been carried
out relatively quickly compared to other public health interven-
tions. Although there is much more research and scientific
discovery now than ever before, the uptake of innovations does
not seem to be much faster than it was 100 y ago. A review of nine
landmark clinical procedures suggested that, on average, it takes a
minimum of 6.3 y for research evidence to reach reviews, papers,
and text books. They estimated that a further 9.3-y transition
period is needed to implement the evidence from scientific
publications [28]. ExpandNet case studies of scaling up reproduc-
tive health interventions indicate that about 10 y is required to
Innovation Element Key Questions for Scale-Up Male Circumcision
Since VMMC scale-up requires substantial infrastructure and human and
financial resources, incremental approaches to scale-up have been used.
Best combination for service delivery scale-up is yet to be determined,
as well as how to balance supply and demand creation.
doi:10.1371/journal.pmed.1001133.t001
Table 1. Cont.
Table 2. Service delivery statistics.
Countries Number of Male Circumcisions Done in Each Calendar Year
DOI Adopter Status
Classification
Estimated Number
of VMMCs to Reach
80% Coverage
Achievement
towards 80%
Coverage
2008 2009 2010 Total
Kenya
a 11,663 80,719 139,905 232,287 Innovator 377,788 61.5%
South Africa 5,190 9,168 131,117 145,475 Early adopter 4,333,134 3.4%
Zambia 2,758 17,180 61,911 81,849 Early adopter 1,949,292 4.2%
Swaziland 1,110 4,336 18,869 24,315 Early adopter 183,450 13.3%
Botswana 0 5,424 5,773 11,197 Early majority 345,244 3.2%
Zimbabwe 0 2,801 11,176 13,977 Early majority 1,912,595 0.7%
Tanzania 0 881 28,562 29,443 Early majority 1,373,271 2.1%
Namibia 0 224 1,763 1,987 Early majority 330,218 0.6%
Mozambique 0 100 7,633 7,733 Early majority 1,059,104 0.73
Uganda 0 0 9,052 9,052 Late majority 4,245,184 0.2%
Rwanda 0 0 1,694 1,694 Late majority 1,746,052 0.1%
Malawi 0 0 300 300 Laggard 2,101,566 ,0.1%
Lesotho 0 0 219 219 Laggard 376,795 0.1%
Total 20,721 120,833 417,974 559,528 20,333,693 2.68%
These data were compiled by the PEPFAR Male Circumcision Technical Working Group and largely reflect data collated from sites funded by this agency.
aNyanza Province only.
doi:10.1371/journal.pmed.1001133.t002
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Whereas in the case of VMMC, within 4 mo of the results of the
three RCTs being released (in December 2006), WHO/UNAIDS
had endorsed VMMC as a safe and effective means of HIV
prevention and published recommendations for the implementa-
tion and scale-up of VMMC programs [19]. Less than a year later,
pilot programs were initiated in the priority countries. Within 3 y
of the release of the WHO/UNAIDS recommendations, the
majority of the 13 priority countries had established national
policies/strategies for HIV prevention that included VMMC and
had begun to initiate service delivery. However, although the
uptake of VMMC RCT evidence was relatively quick, it took
almost two decades from the first cohort data [30] to the RCT
meta-analysis, and implementation research is still insufficient.
Potential predictors of innovation and early adoption of the
VMMC programs identified by this analysis include having a
VMMC focal person, establishing a national policy, and having an
operational strategy, as well as having a pilot or demonstration site
Table 3. VMMC key elements of program scale-up scoring key.
Score
Situational
Analysis Completed
(Full or Selective)
Leadership:
Prominent
National
Champion
Engaged
Leadership:
National
Dedicated Focal
Point in Place
VMMC Policy or
Similar Guidance
Approved
National Strategy
and Operational/
Implementation
Plan Approved
Pilot/Demonstration
Sites: Government
Involvement
3 Completed all or
some elements
before the end
of 2008
Influential national
leader/advocate
engaged for
VMMC in 2007
National VMMC task
force constituted
that meets regularly
by end of 2008
Formal policy or
guidance, either
separate or integrated
into other national policy,
approved by end 2008
Approved by
end of 2008
Pilots set up with
government engagement
by 2008
2 Completed all or
some elements
before the end
of 2009
Influential national
leader/advocate
engaged for
VMMC in 2009
National VMMC task
force constituted by
end of 2009
Policy or equivalent
approved during 2009
Approved during
2009
Pilots set up with
government engagement
by 2009
1 Completed all or
some elements
before the end
of 2010
Influential national
leader/advocate
engaged for
VMMC in 2010
National VMMC task
force constituted by
end of 2010
Draft policy, not yet
approved or completed,
during 2010
Draft or approved
during 2010
Pilots set up with
government engagement
by 2010
0 None, or initial
steps in progress
No leader/advocate
engaged in VMMC
early in the process
No national VMMC
task force
established
No policy or policy
guidance
None No government
involvement or no
pilot programs
doi:10.1371/journal.pmed.1001133.t003
Table 4. Country progress with scaling- up VMMC programs in focal countries (December 2010).
Country Key Elements of VMMC Program Scale-Up
Total Scale-Up
Score)
Situational
Analysis
Completed
a
(Full or Selective)
Leadership:
Prominent
National
Champion
Engaged
Leadership:
National
Dedicated Focal
Point in Place
VMMC Policy or
Similar Guidance
Approved
a
National Strategy
and Operational/
Implementation
Plan Approved
a
Pilot/
Demonstration
Sites: Government
Involvement
B o t s w a n a 3333221 6
K e n y a 3333231 7
L e s o t h o 3011117
M a l a w i 1011115
M o z a m b i q u e 3000014
N a m i b i a 3021129
R w a n d a 1111127
South Africa 2011127
Swaziland 3122231 3
T a n z a n i a 2011228
U g a n d a 2011015
Z a m b i a 2022221 0
Z i m b a b w e 3012118
Score range is 0 (lowest) to 3 (highest).
aThe grading is based on the date of publication or official launch of these documents.
doi:10.1371/journal.pmed.1001133.t004
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PLoS Medicine | www.plosmedicine.org 7 November 2011 | Volume 8 | Issue 11 | e1001133Figure 3. Association of scale-up element scores and Diffusion of Innovation adoption status. The correlation between each of the six
elements of scale-up and DOI adoption status is shown in this figure. The scores obtained (ranging from 0 to 3) for each element by each country is
shown (on the vertical axis) in relation to the adoption status (shown on the horizontal axis). Having a pilot program appears to be the strongest
predictor of adoption status; this can be seen in the linear clustering of the countries. Conversely, having conducted a situational analysis appearst o
the least predictive of adoption status; the clustering of the countries is less linear and appears more random. BOT, Botswana; KEN, Kenya; LES,
Lesotho; MAL, Malawi; MOZ, Mozambique; NAM, Namibia; RWA, Rwanda; SAF, South Africa; SWA, Swaziland; TAN, Tanzania; UGA, Uganda; ZAM,
Zambia; ZIM, Zimbabwe.
doi:10.1371/journal.pmed.1001133.g003
Lessons from Male Circumcision Program Scale-Up
PLoS Medicine | www.plosmedicine.org 8 November 2011 | Volume 8 | Issue 11 | e1001133with government involvement. These are important elements in
confirming country ownership of the program. To create an
environment for increasing country ownership and country-to-
country learning, preparatory multi-stakeholder meetings were
held in Kenya, Lesotho, Swaziland, Tanzania, and Zambia in
2006 [31–36]. Apart from Lesotho, all the other countries that
held early stakeholder consultations are classified within the early
majority, possibly also highlighting the significant role of the
environment.
The DOI and the ExpandNet frameworks both postulate that
the sociopolitical context and cultural relevance of an innovation
are also critical factors influencing the widespread adoption of an
innovation. The DOI theory also emphasizes that opinion leaders
directly affect the adoption of an innovation; this explains why
some innovations are quickly adopted in one setting but fail to take
off in others. It is therefore interesting to note that from our
analysis, the role of having a national champion engaged early on
in the process does not appear to be a predictor of adoption status.
However, despite the low association scores that having a national
champion was shown to have in this analysis, we also know from
our program implementation experience that former Botswana
President Festus Mogae and Kenya’s Prime Minister Raila Odinga
were prominent leaders that championed VMMC programs in
their respective countries [37]. In addition, in 2009, South Africa
acquired a government that prioritized the strengthening of HIV
programs, and on World AIDS Day in December 2009, the new
president of South Africa publicly announced the government’s
determination to move the AIDS agenda forward, saying, ‘‘Let the
politicization and endless debates about HIV and AIDS stop’’ and,
regarding the need to struggle against AIDS as they had done with
apartheid, ‘‘We have no choice but to deploy every effort, mobilize
every resource, and utilize every skill our nation possesses.’’
[38,39] This commitment at the highest level undoubtedly
contributed to the significant number of VMMCs (131,117)
performed in South Africa in 2010. Botswana had strong political
support from their former President Festus Mogae; however, his
presidency ended at the end of March 2008. This may explain
why Bostwana has reached only 3.2% of its 2015 DMPPT target
despite strong momentum in the initial phases.
In Kenya, consistent political support and ongoing community
consultation have allowed implementation challenges to be
addressed as they arise [40]. Kenya established a national VMMC
task force that engaged all the key partners and was replicated at
the provincial level. In addition, in 2007, Kenya initiated
community mobilization activities that engaged community
leaders and other key stakeholders in VMMC program imple-
mentation and generated the demand for services. These activities
helped to overcome some of the initial political and cultural
tensions and to accelerate service delivery [41] This further
highlights the importance of the sociopolitical context and
environment as well as sustained leadership at all levels (described
in the ExpandNet framework) for moving ‘programs from initial
adoption to scale-up. As suggested by the results of this study, it
might therefore be that the consistency of political support and
leadership, at all levels, is more important than just the initial
engagement. This is due to the fact that while adoption is a one-
time event, the scaling up of an innovation such as VMMC is an
iterative process carried out over an extended period of time that
requires continued political support and, in many instances, the
input of decision makers to resolve implementation challenges as
they arise. This ongoing need for political support and the
involvement of decision makers is highlighted in the Kenya
experience. An evaluation of the first year of VMMC program
implementation in Kenya provides insights into some of the
challenges of the Kenya program, including human resource
constraints, inadequate infrastructure, and shortages of equipment
and supplies, as well as difficulties with data management [40].
Despite challenges, the innovative responses that the Kenya
Ministry of Health implemented in collaboration with other
partners facilitated the translation of the national policies and
programs into service delivery. Program managers facing
shortages in human resources and inadequate infrastructure would
not, without strong political support, be able to address these
implementation challenges to the scale-up of an innovation.
While this analysis has not focused on the differences between
country strategies for VMMC scale-up, the choice of strategy
undoubtedly had an impact on VMMC program implementation
and subsequent scale-up. For example, the scale-up strategy of
Botswana has differed from that of other countries that
acknowledge the need for a phase of vertical programs—the
‘‘catch-up’’ phase—to rapidly expand access to safe VMMC
services in addition to a strategy for integration [19]. The
Botswana strategy has focused on the integration of VMMC
within existing health services; this is perhaps a reflection of the
country’s experience with scaling up ART. This may explain why
Botswana has not performed as many VMMCs as the early
adopter countries even though it had a VMMC focal person,
policy, and strategy early on in the process. The timing of when
countries conducted a situation analysis does not appear to have a
bearing on the process of adoption of VMMC programs.
However, for this analysis we did not take into account the type
of situation analysis that was conducted or the process for
dissemination and utilization of the situation analysis findings.
This analysis is not intended to criticize progress in any
particular country; rather, it is an attempt to identify elements
critical to success and underscore some of the challenges to scale-
up. While medical male circumcision has many of the ‘‘COR-
RECT’’ characteristics, it is difficult to scale up the intervention,
particularly as a result of human resources limitations in terms of
both quantity and quality [42]. Also challenging are logistics and
supply management: successful scale-up will in part depend on the
definition and accessibility of commodities essential for VMMC
programming and the appropriate allocation of resources to
support commodity procurement and supply chain logistics [43].
This study suggests that the adoption of a health services
innovation—the development of national policies and strategies,
and the initiation of pilot programs—and program scale-up are
distinct processes. This is clearly illustrated by the limited progress
made towards scale-up by the early adopter countries. Thus,
although the DOI theory was useful for predicting the adoption of
VMMC as an innovation for HIV prevention, it was less useful as
a model to describe what is actually needed to scale up VMMC
services. The ExpandNet framework helps to provide some
insights into the critical components required for scale-up.
Limitations
The VMMC scale-up process has not been well documented in
countries and therefore data were obtained from limited sources.
The total scale-up score has not been used or validated in other
programs and is reliant on assessments by a number of key
informants who have been closely involved in VMMC scale-up at
global and national levels. These individuals were interviewed and
the information triangulated in an attempt to limit the potential
bias. We limited our predictors of adoption status to the elements
defined in the WHO/UNAIDS operational guidance, and yet
there may be other important program elements that are not well
captured in the guidance. We have attempted to draw out some of
these other factors in the discussion but recognize that there may
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quantifiable.
Although the scores have captured the time when the different
milestones were recorded and published, these only indirectly
reflect the timing and pace of scale-up. The date of publication
may have been several months after the work was initiated and/or
completed, so the impact of the element may have been realized.
The number of male circumcisions performed in priority countries
may be underestimated as the data largely reflects male
circumcisions done through programs funded by the United
States President’s Emergency Plan for AIDS Relief (PEPFAR).
However, in many of the priority countries, initial male
circumcision sites have been set up by PEPFAR implementing
partners working closely with government. Finally, the quantita-
tive analyses included in this study were based on a total sample of
13 countries. As such, although the results are indicative of
experiences of these specific countries, the ability to generalize
these findings to other contexts is limited.
Conclusion
Three years after the WHO/UNAIDS recommendations to
expand, promote, and integrate VMMC into comprehensive HIV
prevention packages, VMMC has been adopted as a national HIV
prevention strategy and implementation has been initiated in all of
Box 1. ExpandNet VMMC Components
User organization: the organizations and programs
adopting the innovation
N National Ministries of Health in all 13 priority countries
have taken ownership and are leading the roll out in most
countries.
N All countries have coordination structures (VMMC task
forces) that are functioning to varying degrees. These task
forces are partnerships between the Ministries of Health
and the implementing partners. Kenya and South Africa
also have provincial task forces.
N Human resource constraints—lack of personnel at national
and facility level.
Environment: the social, cultural, political, and
economic context within which scaling up takes place
N Notable political champions in Botswana and Kenya.
Political changes in Botswana and South Africa affected
initial trajectories both negatively and positively.
N Gaining political support – it has been a process to get
political buy-in in some countries
N Global and national advocacy has moved some ‘‘early
adopter’’ countries; peer pressure is working to bring the
‘‘late majority’’ on board. Preparatory stakeholders meet-
ings were held in 2006 in five countries (Lesotho, Kenya,
Tanzania, Swaziland, and Zambia) before the release of the
WHO/UNAIDS recommendations. Regional consultations
were held and national stakeholders meetings held in all
countries after the release of the recommendations.
N Cultural context: issue raised of conflation with female
genital mutilation (which occurs in some parts of Kenya
and Uganda). In Lesotho, Malawi, and South Africa, cultural
issues have been a challenge—the role of traditional
providers has caused much debate and tensions. Lack of
traditional male circumcision in Swaziland facilitated
adoption.
N Legal issues: few countries have laws governing practice of
traditional circumcisers. Task shifting, while successful in
Kenya, is a challenge in other countries.
Resource team: those involved in the development
and testing of the innovation and/or seeking to
promote its wider use
N Developing countries look to WHO to provide norms and
standards, therefore the timely release of the WHO/
UNAIDS recommendations provided guidance for national
policy and strategy development.
N The recommendations address the sociocultural, gender,
and human rights issues that countries need to consider as
well as health service issues, and therefore provide a
comprehensive framework for policy development.
N The UN provided tools and guidance for scale-up,
including operations guidance, legal regulatory tool,
clinical manual for practice, and training, quality assurance,
monitoring, and evaluation.
N Funding from donor organizations was made available and
coordinated to enhance capacity of Ministries of Health
and provider organizations in country.
N Partners in countries available to provide technical support
for scale-up.
N Coordinated international leadership and advocacy sup-
ported country action.
N Strong partnerships between governments and non-
governmental organizations have facilitated program
scale-up in Kenya and, recently, Tanzania.
Scaling up strategy: the means by which the
innovation is communicated, disseminated,
transferred, or otherwise promoted
N Policy development was diverse across countries with
differing types of policy instruments, e.g., Botswana has no
separate policy but strategy with policy elements; Zambia
sent Information note to Cabinet; Kenya developed policy
guidelines; dedicated policies were developed in Lesotho,
Namibia, South Africa, Swaziland, Uganda, and Zimbabwe.
N Country strategies developed that include objectives,
target population, numbers of men to be reached, costs,
service delivery strategies, resource mobilization, monitor-
ing, and evaluation.
N DMPPT used to estimate cost, impact, pace of scale-up,
and to develop or revise strategies.
N Different scale-up strategies have influenced program
implementation. Most countries have ‘‘catch-up’’ strategies
to reach adult men—Kenya, Swaziland, Zimbabwe, Zam-
bia—however, implementation varies; Kenya has gone
ahead with focused campaigns to achieve numbers, while
Botswana is focusing on integrated service delivery.
N Demand creation—matching services to demand is
difficult.
N Communicating partial protection and risk compensation
are challenging.
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projects have been put in place, and by the end of 2010,
approximately 559,528 VMMCs had been performed in the priority
countries, and yet this represents only about 3% of what is needed to
achieve country-derived targets. The variability in progress in scale-
up of male circumcision is evident, and the two diffusion frameworks
suggest that the adoption of VMMC as a HIV prevention innovation
does not guarantee scale-up. A key lesson is the importance of not
only being ready to adopt a new intervention but also ensuring that
those factors that accelerate and sustain program implementation are
built and maintained. The most successful national program
exhibited country ownership and sustained leadership at all levels,
in addition to the adoption of a national policy and strategy to
translate the research into a viable program.
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Background. Every year, more than 2.5 million people
(mostly in sub-Saharan Africa) become infected with HIV, the
virus that causes AIDS. There is no cure for HIV/AIDS and no
HIV vaccine. Consequently, global efforts to combat HIV/
AIDS are concentrating on evidence-based prevention
strategies such as voluntary medical male circumcision
(VMMC). Circumcision—the removal of the foreskin, a loose
fold of skin that covers the head of the penis—reduced HIV
transmission through sexual intercourse by 60% in men
in trials undertaken in sub-Saharan Africa, so in 2007, the
World Health Organization (WHO) and the Joint United
Nations Programme on HIV/AIDS (UNAIDS) recommended
implementation of VMMC programs in countries with a
generalized HIV epidemic and low levels of male
circumcision. They also identified 13 countries in southern
and eastern Africa as high priority countries for rapid VMMC
scale-up. Mathematical modeling suggests that 20.3 million
circumcisions by 2015 and 8.4 million circumcisions between
2016 and 2025 are needed to reach 80% VMMC coverage in
these countries. If this coverage is achieved, it will avert
about 3.4 million new HIV infections through 2025.
Why Was This Study Done? Despite convincing evidence
that VMMC is an effective, cost-saving intervention in the
fight against HIV/AIDS, national VMMC scale-up programs in
the priority countries are currently at very different stages. A
better understanding of the challenges faced by these
programs would help countries still in the early stages of
VMMC scale-up implement their national programs and
would facilitate implementation of other HIV prevention
strategies. In this study, the researchers use the Diffusion of
Innovations (DOI) theory to analyze progress towards VMMC
scale-up in the priority countries and to identify the factors
that may have expedited or hindered program scale-up. This
theory seeks to explain how, why, and at what rate new
ideas and technology spread through cultures. It posits that
a few individuals (‘‘innovators’’) adopt new ideas before they
become mainstream ideas. A few more individuals—the
‘‘early adopters’’—follow the innovators. The ‘‘early majority’’
is the next group to adopt the innovation, followed by the
‘‘late majority’’ and the ‘‘laggards.’’
What Did the Researchers Do and Find? The researchers
used the annual number of VMMCs performed in the priority
countries since 2008 to classify the countries into DOI
adopter categories. They calculated a total scale-up score for
each country based on six key elements of program scale-up
(such as whether and when a VMMC policy had been
approved). Finally, they analyzed the association between
the DOI adopter category and the scores for the individual
scale-up elements to determine which elements predict
adoption and VMMC scale-up. By the end of 2010, about
560,000 VMMCs had been completed, less than 3% of the
target coverage for the priority countries. Kenya, the only
DOI innovator country, had completed nearly two-thirds of
the VMMCs needed to reach its target coverage and was the
only country on track to reach its target. The early adopters
(South Africa, Zambia, and Swaziland) had initiated VMMC
program scale-up soon after the release of the 2007
recommendations and had started VMMC scale-up pilot
programs in 2008 but were far from achieving their VMMC
targets. Having a VMMC focal person, establishing a national
policy, having an operational strategy, and establishing a
pilot program all predicted early adoption of VMMC scale-up.
What Do These Findings Mean? These findings show
that, three years after the WHO/UNAIDS recommendation to
integrate VMMC into comprehensive HIV prevention
programs, VMMC scale-up activities had been initiated in
all the priority countries but that progress towards the 80%
coverage target was variable and generally poor.
Importantly, they show that early adoption of VMMC as a
national program had not necessarily resulted in rapid
program scale-up. Although these findings may not be
generalizable to other settings, they suggest that countries
endeavoring to scale up VMMC (or other HIV prevention
strategies) must not only be ready to adopt VMMC but must
also ensure that all the factors critical to supporting and
accelerating scale-up are incorporated into the scale-up
program. Finally, these findings show that the most
successful national programs are those that involve
country ownership of the program and that have sustained
leadership at all levels to facilitate the translation of research
into national policies and programs.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001133.
N This study is part of a PLoS Collection of articles on VMMC
(http://www.ploscollections.org/VMMC2011) and is further
discussed in a PLoS Medicine Review Article by Hankins
et al. (http://dx.doi.org/10.1371/journal.pmed.1001127)
N Information is available from WHO, UNAIDS, and PEPFAR
on all aspects of HIV/AIDS
N NAM/aidsmap provides basic information about HIV/AIDS,
summaries of recent research findings on HIV care and
treatment, and information on male circumcision for the
prevention of HIV transmission
N Information is available from Avert, an international AIDS
charity on many aspects of HIV/AIDS, including informa-
tion on aspects of HIV prevention, and on HIV/AIDS in
Africa (in English and Spanish)
N The Clearinghouse on Male Circumcision, a resource
provided by WHO, UNAIDS, and other international bodies,
provides information and tools for VMMC policy develop-
ment and program implementation
N Wikipedia has a page on Diffusion of Innovations theory
(note: Wikipedia is a free online encyclopedia that anyone
can edit; available in several languages)
N Personal stories about living with HIV/AIDS are available
through Avert, through NAM/aidsmap, and through the
charity website Healthtalkonline
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